Agent for increasing translation initiation factor or translation elongation factor, and use thereof for medical purposes
作者： Tamaki Ishima , Kenji Hashimoto , 謙二 橋本 , 環 石間
DOI:
关键词:
摘要: [Problem] The purpose of the present invention is to provide a pharmaceutical preparation for preventing and/or treating various diseases, which comprises compound capable increasing translation initiation factor or transcription elongation pharmaceutically acceptable salt thereof as an active ingredient. [Solution] inventors made extensive studies solving problem, and it found first time that increase in (e.g., eIF4A1) eEF1A1) involved NGF-induced neurite potentiating activity minocycline cilostazol, has been accomplished.
lens.org 参考文章(14)
Abhijit Chaudhuri, John Gow, Materials and methods for diagnosis and treatment of chronic fatigue syndrome ,(2006)
Yuko Fujita, Tamaki Ishima, Shinsui Kunitachi, Hiroko Hagiwara, Lin Zhang, Masaomi Iyo, Kenji Hashimoto, Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline Progress in Neuro-psychopharmacology & Biological Psychiatry. ,vol. 32, pp. 336- 339 ,(2008) , 10.1016/J.PNPBP.2007.08.031
Ying Song, Er-Qing Wei, Wei-Ping Zhang, Qiu-Fu Ge, Jian-Ren Liu, Meng-Ling Wang, Xiao-Jia Huang, Xin Hu, Zhong Chen, Minocycline protects PC12 cells against NMDA-induced injury via inhibiting 5-lipoxygenase activation Brain Research. ,vol. 1085, pp. 57- 67 ,(2006) , 10.1016/J.BRAINRES.2006.02.042
Kenji Hashimoto, Tamaki Ishima, Neurite Outgrowth Mediated by Translation Elongation Factor eEF1A1: A Target for Antiplatelet Agent Cilostazol PLoS ONE. ,vol. 6, pp. e17431- ,(2011) , 10.1371/JOURNAL.PONE.0017431
Yoori Choi, Hye-Sun Kim, Ki Young Shin, Eun-Mee Kim, Minji Kim, Hyun-Soo Kim, Cheol Hyoung Park, Yun Ha Jeong, Jongman Yoo, Jean-Pyo Lee, Keun-A Chang, Seonghan Kim, Yoo-Hun Suh, Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer's disease models Neuropsychopharmacology. ,vol. 32, pp. 2393- 2404 ,(2007) , 10.1038/SJ.NPP.1301377
Yasuchika Yamamoto, Yoshinobu Yasuda, Yukio Kimura, Yoshiaki Komiya, Effects of cilostazol, an antiplatelet agent, on axonal regeneration following nerve injury in diabetic rats. European Journal of Pharmacology. ,vol. 352, pp. 171- 178 ,(1998) , 10.1016/S0014-2999(98)00356-2
Gerburg Keilhoff, Lorenz Schild, Hisham Fansa, Minocycline protects Schwann cells from ischemia-like injury and promotes axonal outgrowth in bioartificial nerve grafts lacking Wallerian degeneration. Experimental Neurology. ,vol. 212, pp. 189- 200 ,(2008) , 10.1016/J.EXPNEUROL.2008.03.028
Kenji Hashimoto, Tamaki Ishima, A Novel Target of Action of Minocycline in NGF-Induced Neurite Outgrowth in PC12 Cells: Translation Initiation Factor eIF4AI PLoS ONE. ,vol. 5, pp. e15430- ,(2010) , 10.1371/JOURNAL.PONE.0015430
Lin Zhang, Yukihiko Shirayama, Masaomi Iyo, Kenji Hashimoto, Minocycline attenuates hyperlocomotion and prepulse inhibition deficits in mice after administration of the NMDA receptor antagonist dizocilpine. Neuropsychopharmacology. ,vol. 32, pp. 2004- 2010 ,(2007) , 10.1038/SJ.NPP.1301313
Hajime Baba, Yuki Kubota, Toshihito Suzuki, Heii Arai, Seven cases of late-life depression treated with cilostazol-augmented therapy. Journal of Clinical Psychopharmacology. ,vol. 27, pp. 727- 728 ,(2007) , 10.1097/JCP.0B013E31815A585E